Global Bipolar Disorder Treatment Market Report and Forecast 2024-2032

Global Bipolar Disorder Treatment Market Outlook

The global bipolar disorder treatment market attained a value of USD 5.43 billion in 2023. The market is expected to grow at a CAGR of 2.5% during the forecast period of 2024-2032 to attain a value of USD 6.78 billion by 2032. The growth of the market can be attributed to the rising cases of mental, sexual, and emotional abuse across the globe.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Bipolar Disorder Treatment Market: Introduction and Insights

Bipolar disorder refers to a mental illness which is also known as manic depression. In this condition, the patient experiences extreme mood swings and goes through highs and lows of emotions. These mood swings can jeopardize the patients’ health by affecting their sleep cycle, energy levels, daily activities. It can also severely affect their ability to judgment, their behaviour, and the capacity of making any decision clearly. While some people experience these mood swings at repeated occasions, others do not experience major symptoms. 

Bipolar disorder is a manageable condition if the patient manages to control and handle their mood swings, along with a little help from the physician, it always poses the threat to turn into severe depression, which can be fatal as the patient can become violent and even suicidal. 

The condition can become worse if not taken care of within time, and this can be done by observing the symptoms in the patient. Some of the most common symptoms of the disease are as follows:

• Poor Decision-Making

• Sudden Mood Changes

• Loss of Interest/ Concentration

• Drastic Change in Appetite- Significant Weight Loss/Gain

• Insomnia/ Sleeping Too Much

• Lack of motivation

• Fatigue

• Feelings of Worthlessness/ Excessive Guilt

• Suicidal Thoughts

• Others

Bipolar Disorder Treatment Market Segmentations

This report categorises the global bipolar disorder market into the following segmentations:

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Type

• Bipolar I Disorder- The condition where the patient has the history of one manic episode, with the follow-up by a hypomanic or depressive episode. There are high chances that the episode could have worked as a break from reality.

• Bipolar II Disorder- The patient has had at least one major depressive episode, along with a hypomanic episode, with no history of any manic episode.

• Cyclothymic Disorder- This is when the episodes have occurred twice, whether once in a few years, or once during childhood and then in teenage years.

Market Breakup by Mechanism of Action

• Tricyclic Antidepressants

• Monoamine Oxidase Inhibitors

• Benzodiazepines

• Serotonin-Norepinephrine Reuptake Inhibitors

• Beta-Blockers

• Selective Serotonin Reuptake Inhibitors

• Others

Market Breakup by Diagnosis Method

• Physical Exam

• Psychiatric Assessment

• Mood Charting

Bipolar Disorder Treatment Market Breakup by Treatment Method

• Physical
  • Non-Pharmaceuticals
    • Acupuncture
    • Bright Light Therapy
    • Exercise Therapy
    • Sleep Deprivation
    • Vagus Nerve Stimulation
  • Pharmaceuticals
    • Mood Stabilizers
    • Antidepressants
    • Antipsychotics
    • Adjunctive and Alternative Treatments
• Psychotherapy
  • Therapies
    • Cognitive Behavioural Therapy
    • Group Therapy
    • Interpersonal and Social Rhythm Therapy
    • Vocational Therapy

Market Breakup by Treatment Channel

• Public

• Private

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Bipolar Disorder Market Scenario

According to WHO, 40 million people across the world experienced bipolar disorder in 2019. The prevalence of mental disorders is rising at an alarming rate due to the rising stress among people. About 970 million people, that is one out of eight people, is suffering from some or the other mental disorder. The prevalence rate and incidence rate of the disorder is rising constantly across the globe. While treatment exists, the biggest problem is that the awareness about the treatment is extremely low, along with the restricted access to help and effective care. 

While most of the people are gradually understanding the importance of addressing mental health issues, it is still considered as a taboo in many regions, which makes it difficult for the patients to ask for help, leading to more suicides. 

Treatments and Therapies Used in the Global Bipolar Disorder Treatment Market

PHYSICAL

Non-Pharmaceutical Therapies

The physician would first approach the non-pharmaceutical treatment by suggesting some exercised that can help the patient to relax and attain relief from some of the major symptoms of the condition.

• Exercising daily for more than half an hour can help the patient in releasing the stress hormones and also help in regulating circulation, appetite, and sleep cycle, among many other benefits. Further, the doctor would recommend acupuncture and bright light therapy.

• Acupuncture is used to stimulate the nervous system, which in turn, helps in releasing certain chemicals in the body, especially the brain, spinal cord, and muscles. This leads to higher stimulation of body’s ability to heal naturally. Acupuncture significantly helps in attaining emotional, physical, and mental well-being, helping the patient to a large extent.

• Bright light therapy or phototherapy, on the other hand, helps in regulating the sleep cycle. This therapy helps in gradual shifting of the sleep patterns to the normal levels. In this therapy, timing of light exposure plays a critical role as light should be delivered to the retina for spontaneous awakening. This would help the person to wake up on time so that they are able to sleep on time and thus the sleep cycle is fixed. Healthy sleep cycle automatically reduces the possibility of mood swings and irritability in a person as they are no longer sleep-deficient. It also helps them in being calm and helps their mind function more efficiently.

• Vagus nerve stimulation refers to the treatment where a device is used for stimulating the vagus nerve (which runs through the brainstem from the neck to the chest and then down to the abdomen) using electrical impulses. It is a widely used treatment for conditions like depression and epilepsy. This treatment is also known as the ‘pacemaker of the brain’ because it brings changes in the working of the brain cells.

Pharmaceutical Therapies

The physician usually just prescribes medicines like mood stabilizers, antidepressants, second-generation (atypical) neuroleptics, also known as antipsychotics. Mood stabilizers include drugs with lithium or valproate content. These two can help restrict/prevent the episodes of mood swings or reduce their severity. Lithium also helps in decreasing the risk of suicide and suicidal thoughts. These drugs are also help induce sleep in insomniac patients for some time, till the time their pattern is regulated.

PSYCHOTHERAPY

Psychotherapy is widely regarded as the most effective treatment as it helps the patient to talk about the emotions, thoughts, and behaviours. This helps them let loose of the build up that might have been there for years. The talk therapy helps the patients talk to their physicians without being worried about being judged or mistreated. This can help them get relief from majority of the symptoms as they are able to express their emotions in a much better way.

The psychotherapies have evolved drastically in the past few years due to the rising awareness about its importance among people. With the rising awareness about the importance of addressing mental health issues and the increased support from the government, the demand for psychotherapy is now rising at a rapid pace. This is propelling the bipolar disorder treatment market development. The major therapies include cognitive behavioural therapy, group therapy, vocational therapy interpersonal and social rhythm therapy.

Competitive Landscape of the Bipolar Disorder Treatment Market

The report gives an in-depth analysis of the key players involved in the bipolar disorder treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

• GlaxoSmithKline Plc.

• Novartis International AG

• Takeda Pharmaceutical Industries Ltd.

• Pfizer Inc.

• Allergan Plc. (AbbVie Inc)

• AstraZeneca Plc.

• Bristol-Myers Squibb Co.

• Eli Lilly and Company

• Astellas Pharma Inc.

• Johnson And Johnson Services, Inc.

Key Highlights of the Report